Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Sudo Biosciences Inc.

Headquarters: Menlo Park, CA, United States of America
Year Founded: 2020
Status: Private

BioCentury | Aug 6, 2024
Finance

With an eye toward ‘inflection capital’ for biotechs, TPG focuses new fund on clinical POC

Firm has $580M in to invest in life sciences strategy
BioCentury | Dec 21, 2023
Finance

Dec. 20 Quick Takes: CNS and topical TYK2 inhibitor company Sudo raises $116M series B

Plus: Dynamk’s Kranjac launches new equity firm, PureTech reveals newcos and updates from bluebird, Calliditas and Merck 
BioCentury | Oct 12, 2022
Management Tracks

Wiggins, Simon join C-suite at Vaxcyte

Plus AZ’s Sheldon joining GSK (at last) and updates from Sudo, Walden, 1910 and more
BioCentury | Sep 29, 2022
Finance

Sept. 28 Quick Takes: TYK2 play Sudo emerges with $37M

Plus: Priority review for Pharming and updates from TCR2, Moderna and more
Items per page:
1 - 4 of 4
Help Center
Username
Request a Demo
Request Training
Ask a Question